Lantern Pharma(LTRN) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates FOR IMMEDIATE RELEASE DALLAS—(BUSINESS WIRE)— May 15, 2025 — Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced operational highlights and financial results for the first quarter 2025 ended Ma ...